Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden